Lipid mediator dysregulation in primary pulmonary hypertension

Chest

Volumn 114, Issue 3 SUPPL., 1998, Pages 205S-207S

  Christman, B W ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTACYCLIN;

ARTERY DISEASE; CONFERENCE PAPER; HISTOPATHOLOGY; HUMAN; ICOSANOID METABOLISM; INTRAVENOUS DRUG ADMINISTRATION; LIPID METABOLISM; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; THROMBOCYTE ACTIVATION;

EID: 0031697797     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.3_Supplement.205S     Document Type: Conference Paper

References (16)

1. Loyd JE Atkinson JB Pietra GG Heterogeneity of pathologic lesions in familial primary pulmonary hypertension Am Rev Respir Dis 138 1988 952 957
2. 2 synthesis in vivo in ischemic heart disease: non-invasive evidence of sporadic platelet activation in unstable angina Circulation 72 1985 111 113
3. Smith WL Prostaglandin biosynthesis and it compartmentalization in vascular smooth muscle and endothelial cells Ann Rev Physiol 48 1986 251 262
4. Jones DA Carlton DP McIntyre TM Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines J Biol Chem 268 1993 9049 9054
5. Peters-Golden M Lipid mediator synthesis by lung macrophages Lipscomb MF Russell SW Lung macrophages and dendritic cells in health and disease, 102 1997 Marcel Dekker New York 151 182
6. 2) inhibits platelet adhesion and thrombus formation on subendothelium Blood 53 1979 244 250
7. 2 on transcellular transport of fluorescein dextran through an arterial endothelial monolayer Biochem Pharmacol 36 1987 3808 3813
8. Shirtotani M Yui Y Hattori R U-61, 431F, a stable prostacylin analogue, inhibits the proliferation of bovine vascular smooth muscle cells with little antiproliferative effect on endothelial cells Prostaglandins 41 1991 97 110
9. 2 formation in the human circulation Proc Natl Acad Sci USA 83 1986 5861 5866
10. Mehta JL Yang BC Prostacyclin and thromboxane: role in ischemic heart disease Rubanyi GM Dzau VJ The endothelium in clinical practice—source and target of novel therapies 1997 Marcel Dekker New York 45 70
11. Ko FN Low-affinity thromboxane receptor mediates proliferation in cultured vascular smooth muscle cells of rats Arterioscler Thromb Vasc Biol 17 1997 1274 1282
12. Rich S Hart K Kieras K Thromboxane synthetase inhibition in primary pulmonary hypertension Chest 91 1987 356 360
13. Badesch DB Orton ED Zapp LM Decreased arterial wall prostaglandin production in neonatal calves with severe chronic pulmonary hypertension Am J Respir Cell Mol Biol 1 1989 489 498
14. Christman BW McPherson CD Newman JH An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension N Engl J Med 327 1992 70 75
15. Barst RJ Rubin LJ Long WA A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension N Engl J Med 334 1996 296 301
16. 2 metabolites indicate macrophage activation in primary pulmonary hypertension [abstract] Circulation 96 1997 1427